RESUMO
ABSTRACT: Radiation exposure of a practitioner's fingers is a problem in interventional radiology, and radiation protection gloves (protective gloves) can help reduce such exposure. Several types of protective gloves are commercially available from various manufacturers. In the present study, we compared the protective effects and usability of four types of protective gloves. To investigate the radiation protection effect, we placed normal surgical gloves and the four types of protective gloves on phantom hands with thermoluminescent dosimeters (TLD) attached to the fingertips and the dorsum and palms of the hands. Next, they were irradiated with x rays, and the radiation dose was measured and compared using the TLDs. In terms of usability, 42 medical staff members completed a questionnaire that included seven items, such as finger movability, tactile sensation, grip, and overall satisfaction, which were scored on a 5-point scale. Consequently, the protective effects differed between the gloves, and radiation exposure was lower by 30% to 60% with these gloves compared with surgical gloves. In terms of usability, a difference of 2 to 4 points was noted between the gloves for each questionnaire item. These results suggest that radiation protective gloves can protect the surgeon's fingers from radiation exposure without reducing work efficiency by selecting gloves according to the surgical procedure.
RESUMO
BACKGROUND: The association of cardiovascular diseases (CVD) with liver fibrosis is poorly understood. We aim to assess the association of liver fibrosis by T1-mapping magnetic resonance imaging and CVD in MESA (Multi-Ethnic Study of Atherosclerosis). METHODS AND RESULTS: MESA enrolled 6814 participants free of clinical CVD at baseline (2000-2002). A subsample of participants underwent T1-mapping magnetic resonance imaging 10 years after the baseline (Y10 MESA exam, 2010-2012). Liver T1 maps were generated avoiding vessels and biliary ducts from which native T1 (n=2087) and extracellular volume fraction (ECV, n=1234) were determined. Higher ECV and native T1 were indicators of liver fibrosis. Linear regression analysis evaluated the cross-sectional relationship between liver native T1 and ECV at Y10 MESA exam with a history of CVD events (atrial fibrillation, heart failure, and coronary heart disease [CHD]). Of the 2087 participants (68.7±9.1 years; 46% females), 153 had prior CVD events (78 atrial fibrillation, 25 heart failure, and 78 CHD). History of CVD events was associated with 18.5 ms higher liver native T1 (P<0.001) and 1.4% greater ECV (P=0.06). Prior atrial fibrillation was related to higher liver native T1 (ß=21.1; P=0.001) and greater ECV (ß=2.2; P=0.02), whereas previous heart failure was associated with greater liver ECV (ß=4.1; P=0.02). There was also a relationship of prior CHD with liver native T1 (ß=13; P=0.05) and ECV (ß=1.9; P=0.05), which was attenuated by adjustment for coronary artery calcium score (ß=7.1 and 1.6; P=0.37 and 0.13, respectively). CONCLUSIONS: Liver fibrosis by T1-mapping magnetic resonance imaging is associated with history of heart failure, atrial fibrillation, and CHD in a multiethnic cohort. The association of liver fibrosis and CHD is at least in part mediated by atherosclerosis.
